Drug resistance after failure of initial antiretroviral therapy in resource-limited countries

Clinical Infectious Diseases

Volumn 44, Issue 3, 2007, Pages 453-455

  Gallant, Joel E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CD4 ANTIGEN; DIDANOSINE; LAMIVUDINE; NEVIRAPINE; STAVUDINE; TENOFOVIR; THYMIDINE DERIVATIVE; VIRUS RNA; ZIDOVUDINE;

CD4 LYMPHOCYTE COUNT; COMBINATION CHEMOTHERAPY; DRUG MECHANISM; FATTY LIVER; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS; LIPOATROPHY; LIVER NECROSIS; LIVER TOXICITY; MITOCHONDRIAL TOXICITY; NOTE; PANCREATITIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RESOURCE ALLOCATION; SKIN MANIFESTATION; TREATMENT FAILURE; VIRUS LOAD;

DEVELOPING COUNTRIES; DRUG RESISTANCE, MULTIPLE, VIRAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HIV-1; HUMANS; LAMIVUDINE; NEVIRAPINE; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; TREATMENT FAILURE; VIRAL LOAD;

EID: 33846465029     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/510752     Document Type: Note

References (4)

1. Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W. Options for the second antiretroviral regimen for HIV-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails. Clin Infect Dis 2007; 44:447-52 (in this issue).
2. Pierone G, Mieras J, Gulgin-Coemon D, et al. A pilot study of switch to lopinavir/ritonavir (LPV/r) monotherapy from nonnucleoside reverse transcriptase inhibitor-based therapy. HIV Clin Trials 2006; 7:237-45.
3. Arribas JR, Pulido F, Delgado R, et al. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study). J Acquir Immune Defic Syndr 2005; 40:280-7.
4. Campo RE, Lalanne R, Tanner TJ, et al. Lopinavir/ritonavir maintenance monotherapy after successful viral suppression with standard highly active antiretroviral therapy in HIV-1-infected patients. AIDS 2005; 19:447-9.